Point72 Asset Management
KNSA icon

Point72 Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Point72 Asset Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.2M Buy
659,493
+18,535
+3% +$961K 0.05% 502
2026
Q1 		$30.9M Sell
640,958
-156,179
-20% -$6.92M 0.04% 594
2025
Q4 		$32.9M Buy
797,137
+230,210
+41% +$9.23M 0.04% 603
2025
Q3 		$22M Sell
566,927
-281,622
-33% -$9.15M 0.04% 520
2025
Q2 		$23.5M Sell
848,549
-300,862
-26% -$7.66M 0.05% 438
2025
Q1 		$25.5M Buy
+1,149,411
New +$23.7M 0.06% 382
2022
Q2 		– Sell
-329,798
Closed -$3.28M – 1516
2022
Q1 		$3.28M Sell
329,798
-68,554
-17% -$726K 0.01% 785
2021
Q4 		$4.69M Buy
398,352
+23,252
+6% +$286K 0.02% 689
2021
Q3 		$4.27M Buy
+375,100
New +$4.88M 0.02% 688
2021
Q2 		– Sell
-219,800
Closed -$4.07M – 1073
2021
Q1 		$4.07M Buy
+219,800
New +$4.5M 0.02% 611
2019
Q4 		– Sell
-140,000
Closed -$1.19M – 1100
2019
Q3 		$1.19M Buy
140,000
+105,000
+300% +$1.16M 0.01% 663
2019
Q2 		$474K Buy
+35,000
New +$543K ﹤0.01% 849
2018
Q3 		– Sell
-5,000
Closed -$87K – 1115
2018
Q2 		$87K Buy
+5,000
New +$90.5K ﹤0.01% 935

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Point72 Asset Management's KNSA Position: Q2 2026 in Review

Point72 Asset Management increased its Kiniksa Pharmaceuticals (KNSA) stake by 2.9% in Q2 2026, buying an estimated $961K and bringing the position to 659,493 shares worth $42.2M. The position accounts for 0.05% of the portfolio, ranked #502.

Point72 Asset Management first reported a position in KNSA in Q2 2018 and has held it in 13 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Point72 Asset Management held 659,493 shares of Kiniksa Pharmaceuticals worth $42.2M as of Q2 2026.
  • Point72 Asset Management bought 18,535 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $961K.
  • Kiniksa Pharmaceuticals made up 0.05% of Point72 Asset Management's portfolio in Q2 2026, its #502 holding.
  • Point72 Asset Management first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and has held it in 13 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.